In order to provide the most relevant content to the readers of HealthCare Business News, we're asking you to share a little information about who you are, (it takes two seconds and then you're done).
Esaote North America announced yesterday that its MyLab Gamma ultrasound system received approval from the FDA. It is now available to be purchased in the U.S.
The new system is the size of a laptop and has a variety of applications that allow it to be used in different clinical environments including shared service, dedicated clinics and point-of-care. It can perform cardiac and vascular exams including TEE, strain and stress echo as well as general imaging and women's health.
It features two new image processing technologies called XView and MView that help to speed up exams and increase diagnostic capabilities. It offers a variety of transducers — the convex and endocavity probe are for women's health applications and the 3-D probe can be used during a standard exam.
It can run on battery power, has a quick boot time and a stand-by operating mode, which allows it to be transported easily and used within seconds.
"Today's practices are under increasing pressure to deliver quality health care at an affordable cost," Larry Dentice, president and general manager of Esaote North America, said in a statement. "The portability and affordability of MyLab Gamma helps providers deliver excellent care wherever and whenever it's needed."
